The paper focuses on the pharmaceutical policy of the first two year period of the Trump Administration. Particularly, it focuses on the attempt to to repeal and replace Obamacare and on the news of the Blueprint Program.

Pharmaceutical Policies after the First Two Years of President Trump

Anna Ciammariconi
2019-01-01

Abstract

The paper focuses on the pharmaceutical policy of the first two year period of the Trump Administration. Particularly, it focuses on the attempt to to repeal and replace Obamacare and on the news of the Blueprint Program.
2019
978-94-6236-976-4
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11575/106481
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact